SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH M impact

J&J to Buy Ollin Biosciences for Up to $3.3 Billion

The acquisition gives J&J exposure to Ollin’s eye disease biotech business.

JNJ

Related stories